Stay in touch with NCATS by connecting via social media, joining our listserv for frequent announcements, and subscribing to our monthly e-newsletter.
Explore the full spectrum of translational science, including NCATS' role in transforming knowledge into treatments.
Review a list of all the innovative programs and initiatives that NCATS supports.
NCATS seeks applications through its Tissue Chip for Drug Screening program for research at the International Space Station lab focused on human physiology and disease.
Read about NCATS’ new clinical innovation director, a CTSA Program-supported community-based research consultation service, the Center’s latest annual report, and more.
CTSA Program-supported researchers developed a community-based research (CBR) evaluation model to gauge how consultation services help translate clinical observations into treatments.
NCATS' newly released annual report highlights the Center’s major milestones and achievements and showcases innovative collaborations.
NCATS released a funding opportunity to explore a potential new use of an existing drug or biologic through its Bench-to-Clinic Repurposing initiative.
Michael G. Kurilla is the new director of the Division of Clinical Innovation.
For CTSA Program Hub Applications to Meet FOA Due Dates on or after Feb. 2, 2018
Christopher P. Austin, M.D.
Funded activities under the NCATS Clinical and Translational Science Awards (CTSA) Program (PDF - 89KB)
Interested in creating biologically, physiologically and pharmacologically relevant assays for early-stage drug discovery? Check out our best-practices Assay Guidance Manual.
Learn more about all the ways that potential grantees, partners and collaborators can access NCATS support to advance translational science.
More News & Events …